These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37885888)

  • 1. Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation.
    Li Y; Liang B
    Front Immunol; 2023; 14():1263389. PubMed ID: 37885888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ Transplants.
    Moeller CM; Oren D; Fernandez Valledor A; Rubinstein G; Lotan D; Mehlman Y; Slomovich S; Rahman S; Lee C; Baranowska J; Regan M; Elad B; DeFilippis EM; Hennecken C; Salazar R; Raikhelkar J; Clerkin KJ; Fried J; Lin E; Bae D; Oh KT; Latif F; Topkara VK; Naka Y; Takeda K; Majure D; Uriel N; Sayer G
    Clin Transplant; 2024 Oct; 38(10):e15479. PubMed ID: 39422086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).
    DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR
    J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation.
    Ventura-Aguiar P; Ramirez-Bajo MJ; Rovira J; Bañón-Maneus E; Hierro N; Lazo M; Cuatrecasas M; Garcia-Criado MA; Liang N; Swenerton RK; Cofan F; Cucchiari D; Esforzado N; Montagud-Marrahi E; Oppenheimer F; Piñeiro G; Revuelta I; Torregrosa V; Ahmed E; Soboleva K; Kaur N; Zimmermann BG; Al Haj Baddar N; Demko ZP; Escrig C; Tabriziani H; Gauthier P; Billings PR; Amor AJ; Ferrer J; Campistol JM; Diekmann F
    Transplantation; 2022 Aug; 106(8):1690-1697. PubMed ID: 35289777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
    Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
    Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-derived cell-free DNA as a diagnostic marker for kidney-allograft rejection: A systematic review and meta-analysis.
    Xing Y; Guo Q; Wang C; Shi H; Zheng J; Jia Y; Li C; Hao C
    Biomol Biomed; 2024 Feb; 24(4):731-740. PubMed ID: 38386614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of cell-free DNA quantification and qualification during the first month after lung transplantation.
    Pedini P; Coiffard B; Cherouat N; Casas S; Fina F; Boutonnet A; Baudey JB; Aho P; Basire A; Simon S; Frassati C; Chiaroni J; Reynaud-Gaubert M; Picard C
    Front Immunol; 2023; 14():1183949. PubMed ID: 37180126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators.
    Shah P; Agbor-Enoh S; Lee S; Andargie TE; Sinha SS; Kong H; Henry L; Park W; McNair E; Tchoukina I; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Marboe C; Berry GJ; Valantine HA;
    Circ Heart Fail; 2024 Apr; 17(4):e011160. PubMed ID: 38375637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches.
    Edwards RL; Menteer J; Lestz RM; Baxter-Lowe LA
    Biomark Med; 2022 Apr; 16(5):401-415. PubMed ID: 35195028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis.
    Wijtvliet VPWM; Plaeke P; Abrams S; Hens N; Gielis EM; Hellemans R; Massart A; Hesselink DA; De Winter BY; Abramowicz D; Ledeganck KJ
    Transpl Int; 2020 Dec; 33(12):1626-1642. PubMed ID: 32981117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection.
    Keller MB; Tian X; Jang MK; Meda R; Charya A; Ozisik D; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S
    J Heart Lung Transplant; 2024 Apr; 43(4):563-570. PubMed ID: 37972825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators.
    Mehta A; Goldberg J; Bagchi P; Marboe C; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Cochrane A; Tchoukina IF; Kong H; Lohmar BJ; Mcnair E; Valantine HA; Agbor-Enoh S; Berry GJ; Shah P
    J Heart Lung Transplant; 2024 Oct; ():. PubMed ID: 39424014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal Transplantation.
    Oellerich M; Budde K; Osmanodja B; Bornemann-Kolatzki K; Beck J; Schütz E; Walson PD
    Ther Drug Monit; 2023 Feb; 45(1):20-25. PubMed ID: 36127770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease States.
    Gauthier PT; Madill-Thomsen KS; Demko Z; Prewett A; Gauthier P; Halloran PF;
    Transplantation; 2024 Apr; 108(4):898-910. PubMed ID: 38150492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
    Kim PJ; Olymbios M; Siu A; Wever Pinzon O; Adler E; Liang N; Swenerton R; Sternberg J; Kaur N; Ahmed E; Chen YA; Fehringer G; Demko ZP; Billings PR; Stehlik J
    J Heart Lung Transplant; 2022 Jul; 41(7):919-927. PubMed ID: 35577713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single center study investigating the clinical association of donor-derived cell-free DNA with acute outcomes in lung transplantation.
    Noda K; Snyder ME; Xu Q; Peters D; McDyer JF; Zeevi A; Sanchez PG
    Front Transplant; 2023; 2():1339814. PubMed ID: 38993874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients.
    Zhao D; Zhou T; Luo Y; Wu C; Xu D; Zhong C; Cong W; Liu Q; Zhang J; Xia Q
    Sci Rep; 2021 Jan; 11(1):1138. PubMed ID: 33441886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.